Research Portal

Current assessment of risk-benefit by regulators: Is it time to introduce decision analyses?

Research output: Contribution to conference › Paper

Standard Standard

Current assessment of risk-benefit by regulators: Is it time to introduce decision analyses? / Hughes, D.; Hughes, D.A.; Pirmohamed, M. et al.
2007. Paper presented at 8th European Association for Clinical Pharmacology and Therapeutics, Amsterdam, Netherlands.

Research output: Contribution to conference › Paper

HarvardHarvard

Hughes, D, Hughes, DA, Pirmohamed, M & Bayoumi, A 2007, 'Current assessment of risk-benefit by regulators: Is it time to introduce decision analyses?', Paper presented at 8th European Association for Clinical Pharmacology and Therapeutics, Amsterdam, Netherlands, 3/01/01.

APA

Hughes, D., Hughes, D. A., Pirmohamed, M., & Bayoumi, A. (2007). Current assessment of risk-benefit by regulators: Is it time to introduce decision analyses?. Paper presented at 8th European Association for Clinical Pharmacology and Therapeutics, Amsterdam, Netherlands.

CBE

Hughes D, Hughes DA, Pirmohamed M, Bayoumi A. 2007. Current assessment of risk-benefit by regulators: Is it time to introduce decision analyses?. Paper presented at 8th European Association for Clinical Pharmacology and Therapeutics, Amsterdam, Netherlands.

MLA

Hughes, D. et al. Current assessment of risk-benefit by regulators: Is it time to introduce decision analyses?. 8th European Association for Clinical Pharmacology and Therapeutics, Amsterdam, Netherlands, 03 Jan 0001, Paper, 2007.

VancouverVancouver

Hughes D, Hughes DA, Pirmohamed M, Bayoumi A. Current assessment of risk-benefit by regulators: Is it time to introduce decision analyses?. 2007. Paper presented at 8th European Association for Clinical Pharmacology and Therapeutics, Amsterdam, Netherlands.

Author

Hughes, D. ; Hughes, D.A. ; Pirmohamed, M. et al. / Current assessment of risk-benefit by regulators: Is it time to introduce decision analyses?. Paper presented at 8th European Association for Clinical Pharmacology and Therapeutics, Amsterdam, Netherlands.

RIS

TY - CONF

T1 - Current assessment of risk-benefit by regulators: Is it time to introduce decision analyses?

AU - Hughes, D.

AU - Hughes, D.A.

AU - Pirmohamed, M.

AU - Bayoumi, A.

PY - 2007/8/1

Y1 - 2007/8/1

M3 - Paper

T2 - 8th European Association for Clinical Pharmacology and Therapeutics, Amsterdam, Netherlands

Y2 - 3 January 0001

ER -